La-Croix-Saint-Ouen, France

Catherine Bedel

This inventor holds 1 USPTO granted patent. Top assignee: Cis Bio International. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine Bedel. Retrieved from https://idiyas.com/inventor/catherine-bedel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Catherine Bedel: Innovator in Metalloporphyrin Derivatives

Introduction

Catherine Bedel is a notable inventor based in Lacroix St. Ouen, France. She has made significant contributions to the field of chemistry, particularly in the development of metallized porphyrin derivatives. Her work has implications in various applications, including antitumor agents and diagnostic tools.

Latest Patents

Catherine Bedel holds one patent related to her research on derivatives of porphyrin and metalloporphyrins. The patent describes metallized porphyrin derivatives that have specific formulas, wherein the R and M variables are defined in the specification. These derivatives are recognized for their potential uses as antitumor agents, diagnostic agents, or in therapeutic applications.

Career Highlights

Catherine is associated with Cis Bio International, where she continues to advance her research and innovation in the field. Her work has garnered attention for its potential impact on medical and therapeutic practices.

Collaborations

Catherine collaborates with esteemed colleagues, including Laurent Mauclaire and Michel Pereyre, who contribute to her research endeavors and enhance the scope of her projects.

Conclusion

Catherine Bedel's innovative work in metalloporphyrin derivatives showcases her dedication to advancing scientific knowledge and developing practical applications in medicine. Her contributions are significant in the ongoing quest for effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…